Skip to content

Drug interactions

Pembrolizumab + Siponimod

Severity: Moderate

Pembrolizumab and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pembrolizumab is a PD-1 checkpoint inhibitor that enhances immune activity and may cause immune-related adverse events, while siponimod sequesters lymphocytes. The net effect is unpredictable, and corticosteroids used for immune toxicity add infection risk.

What this interaction means in plain words

Pembrolizumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pembrolizumab belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Pharmacodynamic: opposing immune effects of S1P modulation and PD-1 blockade with unpredictable net result.

What to do

Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pembrolizumab and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pembrolizumab with Siponimod?

MediHelp rates the interaction as moderate. Pembrolizumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pembrolizumab is a PD-1 checkpoint inhibitor that enhances immune activity and may cause immune-related adverse events, while siponimod sequesters lymphocytes. The net effect is unpredictable, and corticosteroids used for immune toxicity add infection risk.

How serious is the interaction between Pembrolizumab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in